Total
0
Shares
BOD Australia (ASX:BOD) - CEO, Jo Patterson - The Market Herald
CEO, Jo Patterson
Source: Jo Patterson
  • Medicinal cannabis company Bod Australia (BDA) has launched nine hemp-based products in collaboration with Swisse Wellness
  • More than 2000 leading retailers such as Coles, Priceline and Chemist Warehouse will receive these products
  • This launch marks the first hemp-based range for Swisse in Australia
  • The range is primarily made-up of skincare products, but soft gel caps containing hemp seed oil will also be launched
  • Bod's share price is up a steady 21.4 per cent and shares are trading for 17 cents each

Medicinal cannabis company Bod Australia (BDA) has launched nine hemp-based products in collaboration with Swisse Wellness.

More than 2000 stores will receive these products and they will initially be available in leading retailers such as Coles, Priceline, and Chemist Warehouse.

"Launching nine products with such as recognised and trusted brand in Swisse is game-changing for Bod," CEO Jo Patterson said.

"We anticipate considerable consumer uptake once stock is available for purchase. We look forward to providing regular updates to shareholders as sales build," she added.

Following a partnership that Bod secured with Swisse's parent company, Health and Happiness Group, in 2019, this launch marks the first of the Swisse hemp-based range in Australia.

The range is primarily made-up of skincare products, but soft gel caps containing hemp seed oil will also be launched.

Initial interest from the large retail groups has already been encouraging.

"Swisse's Hemp product rollout is a strategic move for the brand as we focus on offering innovative wellness solutions that respond to consumer shifts and growing demand," Swisse Managing Director Nick Mann commented.

"We are preparing our business for the legalisation of CBD in Australia, so we can take advantage of the market with product innovation in partnership with Bod," he added.

Swisse will undertake the sales and marketing campaigns, as well as in-store promotions.

To broaden its footprint and progress into the international market, Bod and Health and Happiness will continue working together to create new hemp-based products.

Bod's share price is up a steady 21.4 per cent and shares are trading for 17 cents each at 2:38 pm AEDT.


Subscribe


BDA by the numbers
More From The Market Herald
Osprey Medical (ASX:OSP) - President & CEO, Mike McCormick - The Market Herald

" Osprey Medical (ASX:OSP) signs distribution deal with RHCG for DyeVert tech

Osprey Medical (OSP) has struck a deal to have its tech distributed and sold in Australia and New Zealand for the first time.
Incannex Healthcare (ASX:IHL) - Chief Medical Officer, Dr Sud Agarwal (left) & CEO, Joel Latham (right) - The Market Herald

" Incannex Healthcare (ASX:IHL) receives ethics approval for OSA trial

Medicinal cannabis company Incannex Healthcare (IHL) has received ethics approval for a phase 2b clinical trial investigating its obstructive sleep apnoea (OSA) treatment.
MyFiziq (ASX:MYQ) - CEO & Co Founder, Vlado Bosanac - The Market Herald

" MyFiziq (ASX:MYQ) JV completes $2M funding round

MyFiziq (MYQ) joint venture company, Body Composition Technologies, has completed a $2 million funding round.
Aperion Investment Group- Founder, Christian Angermayer - The Market Herald

" Bionomics (ASX:BNO) receives FIRB approval for Aperion’s 52pc stake

Bionomics (BNO) has received Foreign Investment Review Board (FIRB) approval for Aperion Investment Group to nab a 52 per cent stake in the